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INTRODUCTION
A right bundle branch block (RBBB) is a common electrocar-
diographic abnormality in patients with heart transplantation 
(HT), with a prevalence rate of 12–79%.1-4 Although limited 
studies have reported conflicting clinical outcomes, the occur-
rence of RBBB after HT appears to be associated with poor clin-
ical outcomes, including increased mortality, especially in pa-
tients with progressive RBBB.4-6 Small studies have described 
inflammatory infiltration related with graft rejection in the 
conduction system, as well as in the myocardium. Foerster7 re-
ported that the conduction system was involved in 8 cases 
among 11 allografts with acute graft rejection, and Calzolari, et 
al.8 reported that complete or incomplete RBBB was founded 
in 11 cases out of 12 transplanted hearts with acute or chronic 
rejection in necropsy histologic study. Chan, et al.9 indicated 
that conduction abnormalities including RBBB could be asso-
ciated with rejection, which might result in worse clinical out-
comes.
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Purpose: We aimed to examine associations between right bundle branch block (RBBB) following heart transplantation (HT) 
and graft rejection.
Materials and Methods: We investigated 51 patients who underwent endomyocardial biopsies, electrocardiogram, right-side car-
diac catheterization, and echocardiography at 1 month and 1 year after HT. We classified patients into four groups according to 
the development of RBBB, based on electrocardiogram at 1 month and 1 year: 1) sustained RBBB, 2) disappeared RBBB, 3) newly 
developed RBBB, and 4) sustained non-RBBB. The RBBB was defined as an RSR' pattern in V1 with a QRS duration ≥100 ms on 
electrocardiogram. 
Results: The newly developed RBBB group (n=13, 25.5%) had a higher rate of new onset graft rejection (from grade 0 to grade ≥1R, 
30.8% vs. 10.0% vs. 21.4%, p=0.042) at 1 year, compared with sustained RBBB (n=10, 19.6%) and sustained non-RBBB group (n=28, 
54.9%). In contrast, the incidence of resolved graft rejection (from grade ≥1R to grade 0) was higher in the sustained RBBB group 
than the newly developed RBBB and sustained non-RBBB groups (70.0% vs. 7.7% vs. 25.0%, p=0.042). Left atrial volume index was 
significantly higher in the newly developed RBBB group than the sustained RBBB and sustained non-RBBB groups (60.6±25.9 mL/m2 
vs. 36.0±11.0 mL/m2 vs. 38.4±18.1 mL/m2, p=0.003). 
Conclusion: Close monitoring for new development of RBBB at 1 year after HT, which was associated with a higher incidence of 
new onset graft rejection, may be helpful to identify high risk patients for graft rejection.
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However, there were not enough data about the patterns of 
development of RBBB and its relation with graft rejection and 
hemodynamic parameters following HT. Therefore, we sought 
to investigate the time-course development of RBBB on elec-
trocardiogram (ECG) and its association with graft rejection, 
echocardiographic parameters, and invasive hemodynamic 
parameters in HT patients.
MATERIALS AND METHODS
Study population
We performed a retrospective analysis of 79 patients who un-
derwent bicaval orthotopic HT at Severance Cardiovascular 
Hospital from 2011 to 2015. The study protocol was approved 
by the Institutional Review Board of Severance Hospital (No. 
4-2013-0665). All patients received basiliximab induction 
therapy, followed by triple immunosuppressive therapy (ta-
crolimus, mycophenolate mofetil, prednisolone). We exclud-
ed patients (n=17) who died due to fatal infection or multi-or-
gan failure within 1 month and patients (n=11) who did not 
undergo either endomyocardial biopsy, echocardiography, or 
right-side cardiac catheterization at 1 month and 1 year after HT. 
Finally, we analyzed 51 patients who underwent all of previously 
mentioned exams at 1 month and 1 year after HT (Fig. 1).
Based on ECG at 1 month and 1 year following HT, four 
groups of patients were identified: 1) sustained RBBB group 
(RBBB at 1 month and remaining RBBB at 1 year), 2) disappeared 
RBBB group (RBBB at 1 month and ECG at 1 year showed non-
RBBB), 3) newly developed RBBB group (ECG at 1 month was 
non-RBBB, but ECG at 1 year showed RBBB), and 4) sustained 
non-RBBB group (ECG at 1 month was non-RBBB and remain-
ing non-RBBB at 1 year). 
Electrocardiography and endomyocardial biopsy
Standard 12-lead ECGs were obtained in the hospital after HT 
and at the outpatient clinic during follow-up. The RBBB was 
defined as an RSR' pattern in V1 with an R' amplitude of at least 
0.2 mV with a QRS duration ≥100 ms on ECG.6 PR interval was 
defined as the interval from the onset of the P wave to the end 
of the PR segment, and was measured from the limb lead in 
which the interval was longest.10 The diagnosis of acute graft 
rejection was made by endomyocardial biopsy according to 
the International Society for Heart and Lung Transplantation 
(ISHLT) 2004 grading system: Grade 0, no rejection; Grade 1R, 
mild; Grade 2R, moderate; or Grade 3R, severe.11 
Echocardiography and right-side cardiac 
catheterization
Two-dimensional echocardiography was performed to mea-
sure the dimensions and volume of the left ventricle (LV) and 
left atrium (LA), and LV ejection fraction was measured by the 
Simpson method as recommended.12 Right-side cardiac cath-
eterization was performed to acquire hemodynamic data si-
multaneously during endomyocardial biopsy, and the following 
variables were measured: systolic, diastolic, and mean pressure 
of the pulmonary artery (PA) and right ventricle (RV) and pul-
monary capillary wedge pressure.
Statistical analysis
Continuous variables including hemodynamic and echocar-
diographic parameters are expressed as mean±SD, and they 
were compared using Student’s t test. Discrete variables are ex-
pressed as percentages and were compared using the chi-square 
test and Fisher exact test for small groups. All statistical analy-
ses were conducted using SPSS statistical software (ver. 21.0; 
IBM Corp., Armonk, NY, USA). A two-sided p value of <0.05 
was considered as statistically significant.
RESULTS
Patient clinical characteristics
The mean age of all donors was 33.6±11.0 years, and 64.7% were 
male. The mean age of all recipients was 41.7±15.1 years, and 
58.8% were male. Table 1 shows the patient clinical character-
istics of each group. Total ischemic time and immunosuppres-
sive drug regimens during follow up were not different among 
each group. The prevalence of RBBB in our study was 19.6% (n= 
10) at 1 month and 45.1% (n=23) at 1 year after HT. There were 
10 patients (19.6%) with sustained RBBB, 0 patients (0%) with 
disappeared RBBB, 13 patients (25.5%) with newly developed 
RBBB, and 28 patients (54.9%) with sustained non-RBBB. 
Echocardiographic and invasive hemodynamic 
parameters according to the development of RBBB
Details on RBBB development on ECG, right-side cardiac cath-
eterization, echocardiography, and endomyocardial biopsy in 
each group are listed in Table 2. The newly developed RBBB 
Non-RBBB 
(n=41, 80.4%)
1 month 
after HT
1 year 
after HT
HT (n=51)
RBBB 
(n=10, 19.6%)
RBBB 
(n=10, 19.6%): 
sustained RBBB
Non-RBBB 
(n=0, 0%): 
disappeared RBBB
Non-RBBB 
(n=28, 54.9%): 
sustained non-RBBB
RBBB 
(n=13, 25.5%): 
newly developed RBBB
Fig. 1. Flow diagram of each group according to the development of RBBB 
after HT. HT, heart transplantation; RBBB, right bundle branch block.
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group had significantly longer PR interval at 1 year than the sus-
tained RBBB group and sustained non-RBBB group (164.8±13.7 
ms vs. 148.6±25.7 ms vs. 149.2±18.3 ms, respectively, p=0.044). 
However, no invasive hemodynamic parameters measured by 
right-side cardiac catheterization were different between each 
group at 1 month and 1 year following HT. LA volume index 
was significantly higher in the newly developed RBBB group 
than the sustained RBBB and sustained non-RBBB groups 
(60.6±25.9  mL/m2 vs. 36.0±11.0  mL/m2 vs. 38.4±18.1 mL/m2, 
respectively, p=0.003). LV ejection fraction and parameters re-
lated with LV diastolic function were not significantly different 
among the groups.
Graft rejection after HT 
As shown in Table 3, we identified 4 cases (30.8%) of new on-
set graft rejection (from grade 0 to grade ≥1R) in the newly de-
veloped RBBB group, which was higher than that in the other 
groups (1 case, 10.0% in sustained RBBB vs. 6 cases, 21.4% in 
sustained non-RBBB group). Interestingly, 7 patients (70.0%) 
in the sustained RBBB group experienced resolved histologic 
finding (from grade ≥1R to grade 0) over time, compared to 
other groups (7.7% in newly developed RBBB vs. 25.0% in sus-
tained non-RBBB group). Among three patients with graft re-
jection Grade 2R at 1 year, two patients were in the newly devel-
oped RBBB group; one patient was in the sustained non-RBBB 
group. 
In our HT patients, the PR interval (142.6±15.6 ms vs. 152.7± 
19.9 ms, p=0.002) and QRS duration (87.2±13.3 ms vs. 97.0±14.8 
ms, p<0.001) increased significantly from 1 month to 1 year 
after HT. Furthermore, 9 patients (81.8%) with new onset graft 
rejection (from grade 0 to grade ≥1R) had a significantly longer 
PR (≥153 ms) interval at 1 year than other groups (58.3% in no 
change of GR vs. 38.5% in no evidence of GR vs. 26.7% in resolv-
ing of GR) (Table 4).
DISCUSSION
The principal findings of this study are that 1) newly devel-
oped RBBB was associated with higher new onset graft rejec-
tion, higher LA volume index, and longer PR interval at 1 year 
and that 2) individuals with sustained RBBB experienced a 
significantly higher incidence of resolved graft rejection at 1 year, 
compared with newly developed RBBB and sustained non-
RBBB.
The occurrence of conduction abnormalities after HT is well 
known, and the most common of these is RBBB. The preva-
lences of RBBB in the present study population were 15.9% at 1 
month and 36.5% at 1 year, similar to previous studies (12% to 
79%). Most previous studies reported that the development of 
RBBB and QRS width increased over the time after HT.4,13-15 
Meanwhile, several studies indicated that the occurrence of 
conduction disorders after HT was related with longer ischemic 
time, extracorporeal circulation time, surgery-related myocar-
dial damage, and graft rejection.3,4,16 Among conduction dis-
orders, the occurrence of RBBB immediately within 1 month 
after HT could pose different clinical implications from those 
with the occurrence of RBBB later. Since the right bundle branch 
has a unique anatomical structure, it might be susceptible to 
damage during HT: much of its septal course is near the en-
Table 1. Patient Clinical Characteristics
Sustained RBBB 
(n=10, 19.6%)
Newly developed 
RBBB (n=13, 25.5%)
Sustained non-RBBB 
(n=28, 54.9%)
p value
Donor data
Male sex 9 (90) 7 (53.8) 17 (60.7) 0.147
Age (yr) 30.4±9.5 38.0±10.5 32.7±11.5 0.223
Body surface area (m2) 1.76±0.17 1.74±0.17 1.76±0.17 0.690
Preoperative LVEF (%) 64.9±6.9 59.7±6.1 62.7±6.7 0.180
Cause of death on donor 0.117
Hypoxic brain damage 2 (20.0) 3 (23.1) 9 (32.1)
Non-traumatic brain hemorrhage 6 (60.0) 2 (15.4) 4 (14.3)
Traumatic brain hemorrhage 2 (20.0) 7 (53.8) 14 (50.0)
Others 0 (0.0) 1 (7.7) 1 (3.6)
Recipient data
Male sex 5 (50.0) 9 (69.2) 16 (57.1) 0.596
Age (yr) 38.3±16.0 44.9±14.5 41.5±15.1 0.583
Body surface area (m2) 1.65±0.25 1.71±0.23 1.68±0.19 0.470
Preoperative LVEF (%) 23.9±9.9 25.6±9.0 22.2±14.0 0.694
Total ischemic time (min) 163.7±53.6 159.0±36.9 145.7±36.5 0.401
Previous open-heart surgery history 3 (30.0) 7 (53.8) 6 (21.4) 0.125
LVEF, left ventricular ejection fraction; RBBB, right bundle branch block.
Values are presented as n (%) or mean±SD. 
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docardium and consists of narrow cylindrical tubes.17 Also, bi-
atrial anastomosis and clockwise rotation of a transplanted 
heart, as a result of the surgical technique, could be other caus-
ative factors for RBBB.1,15,18,19 Considering these factors, our 
study indicated that the occurrence of RBBB early within 1 
month following HT was less likely to be related with early graft 
rejection.
Our study showed that the newly developed RBBB after 1 
month later following HT could be related with graft rejection. 
As in our findings, Osa, et al.6 showed that progressive RBBB, 
during which QRS width increases more than 0.5 mm during 
follow-up, was associated with a poorer long-term prognosis 
than non-progressive RBBB and related to a greater number of 
treatable rejections. Also, patients with gradually worsening 
conduction abnormalities exhibited significant differences in 
the number of rejections to treatment, suggesting a correlation 
between the progression of conduction abnormalities and 
poor clinical outcomes, as described in the study of Leonelli, et 
al.3,20 On the other hand, the sustained RBBB group in our study 
had a relatively low rejection rate and a higher resolution of 
histologic findings during follow up, compared with the newly 
developed RBBB group. The absence of changes in ECG during 
follow up might be more histologically stable, although further 
research is needed to evaluate and clarify this.
Mild graft rejection, such as Grade 1R on the revised ISHLT 
grading system, was previously found to be the strongest pre-
dictor for severe graft rejection of more than Grade 2R, suggest-
ing short-term follow up seems to be warranted.21 Furthermore, 
Table 2. Electrocardiographic, Echocardiographic, and Invasive Hemodynamic Parameters and Endomyocardial Biopsy Results in Each Group
Sustained RBBB (n=10) Newly developed RBBB (n=13) Sustained non-RBBB (n=28)
1 month 1 year 1 month 1 year 1 month 1 year
Electrocardiogram
QRS width (ms) 109.6±11.1* 112.6±8.8 87.0±10.4 110.6±12.1 82.0±8.7 90.1±10.1||
PR interval (ms) 133.4±13.0 148.6±25.7 143.8±14.6 164.8±13.7§ 145.4±16.5 149.2±18.3
QTc (ms) 456.8±27.0 466.5±22.2 446.0±25.8 441.9±23.0 446.0±25.8 441.9±23.0
Right heart catheterization
RVSP (mm Hg) 30.2±7.9 28.3±7.4 31.1±6.6 26.3±6.8 30.3±6.6 28.4±7.8
RVDP (mm Hg) 4.5±7.2 1.3±4.0 2.6±2.4 0.1±3.5 3.2±3.3 1.6±2.7
RVMP (mm Hg) 16.0±7.2 12.4±2.7 14.8±4.7 11.0±5.1 15.0±3.8 14.4±5.1
PASP (mm Hg) 27.6±8.5 26.5±5.7 29.1±6.2 24.8±7.5 29.0±7.7 27.4±6.5
PADP (mm Hg) 10.7±2.9 11.3±2.8 13.4±4.3 9.9±4.4 12.3±4.6 12.8±4.7
PAMP (mm Hg) 18.3±3.2 18.2±3.9 18.0±5.7 17.0±5.7 19.7±5.8 19.7±5.4
PCWP (mm Hg) 8.7±4.3 9.6±2.8 12.8±4.5 9.2±3.8 10.7±3.3 12.1±6.1
Echocardiographic data
LVEF (%) 68.2±6.3 65.2±6.8 66.0±7.2 68.2±4.3 67.5±5.5 65.0±7.9
LVMI (g/m2) 94.1±21.5 84.5±13.1 106.9±36.7 93.9±28.6 94.2±24.9 81.7±17.3
LAVI (mL/m2) 38.6±12.8 36.0±11.0 63.2±24.1† 60.6±25.9‡ 39.2±13.9 38.4±18.1
E velocity (m/s) 0.71±0.12 0.70±0.21 0.83±0.27 0.79±0.23 0.73±0.21 0.75±0.17
E’ velocity (cm/s) 6.3±2.4 8.0±2.8 5.7±2.2 7.1±2.7 6.2±1.8 7.7±2.0
E/E’ 12.4±3.7 9.3±3.1 15.2±5.8 11.8±4.1 12.7±4.5 10.2±2.8
RVSP (mm Hg) 33.8±9.1 29.2±8.4 35.1±11.6 26.0±8.7 34.6±9.3 29.5±5.1
TAPSE (mm) 14.0±3.9 16.8±0.6 15.6±3.4 16.0±2.6 15.7±2.9 15.9±2.2
TV TDI S’ (cm/s) 9.1±1.8 10.2±2.0 8.6±3.2 10.0±2.2 8.6±2.4 9.3±2.6
Histology 
Graft rejection (≥1) 7 (70.0) 1 (10.0) 6 (46.2) 9 (69.2) 14 (50.0) 13 (46.4)
Immunosuppressant level
Tacrolimus level (ng/mL) 10.9±5.8 9.5±3.8 8.9±2.1 7.9±2.2 9.5±3.5 9.8±3.1
LAVI, left atrial volume index; LVMI, left ventricular mass index; PCWP, pulmonary capillary wedge pressure; RBBB, right bundle branch block; RVSP, right ven-
tricular systolic pressure; RVDP, right ventricular diastolic pressure; RVMP, right ventricular mean pressure; PASP, pulmonary artery systolic pressure; PADP, pul-
monary artery diastolic pressure; PAMP, pulmonary artery mean pressure; PCWP, pulmonary capillary wedge pressure; TAPSE, tricuspid annular plane systolic 
excursion; TV TDI S’, tricuspid valve tissue Doppler imaging S’.
Values are expressed as mean±SD or number (percentage). 
p<0.05, by ANOVA with post hoc test using Bonferroni technique (*sustained RBBB group vs. newly developed RBBB group and sustained non-RBBB group at 1 
month following heart transplantation; †newly developed RBBB group vs. sustained RBBB group and sustained non-RBBB group at 1 month following heart 
transplantation; ‡newly developed RBBB group vs. sustained RBBB group and sustained non-RBBB group at 1 year following heart transplantation; §newly devel-
oped RBBB group vs. sustained non-RBBB group at 1 year following heart transplantation; ||sustained non-RBBB group vs. sustained RBBB group and newly de-
veloped RBBB group at 1 year following heart transplantation).
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mild graft rejection at the conduction system, including the 
atrioventricular (AV) node and right bundle branch, could be 
associated with the development of RBBB, PR interval prolon-
gation, and AV block.8 Prolonged PR interval, another type of 
conduction abnormality, was linked to conduction system fi-
brosis, and graft rejection.10,22 Some studies reported AV block 
was associated with a higher risk of graft rejection, which re-
sulted from lymphocyte infiltration, inflammation, myocyte 
necrosis or fibrosis at the conduction system.23-26 Furthermore, 
Calzolari, et al.8 reported that appearance of first-degree AV 
block in a HT recipient may be suggestive of involvement of 
the conduction system with impending third-degree block. Also, 
Chan, et al.9 reported early signs of first degree AV block after 
HT may portend aggravated conduction abnormalities with 
occurrence of subclinical, isolated rejection of the conduction 
system. In our study, at 1 year after HT, newly developed 
RBBB posed a significantly longer PR interval, and PR interval 
in patients who had new onset graft rejection at 1 year was 
significantly longer than those in patients without new onset 
graft rejection (161.5±12.2 ms vs. 150.8±20.9 ms, p=0.041) (de-
tailed in Supplementary Table 1, only online). Accordingly, we 
suggest that newly developed RBBB with a relatively longer PR 
interval at 1 year following HT might be strongly associated 
with graft rejection involving conduction system. 
Our study had several limitations. First, this study was a ret-
rospective single-center study, even though the data were col-
lected in a prospective manner. Second, our study population 
was too small, and the follow-up period was too short, only up 
to 1 year. Third, endomyocardial biopsies were just performed 
two times at 1 month and at 1 year following HT. It remains 
still unknown what kind of histologic changes have occurred 
in relation to ECG between 1 month and 1 year after HT. How-
ever, a recent study showed that morbidity and mortality of 
lower frequency routine surveillance EMB were comparable 
with data from the ISHLT registry.27 Fourth, we did not ana-
lyze these new parameters for graft rejection in all the HT re-
cipients. Considering the prognostic importance of antibody 
mediated rejection and donor specific antibody in HT recipi-
ents, further study of the relationship between RBBB and these 
parameters is warranted. Fifth, we did not measure rejection-
related biomarkers, such as natriuretic peptide, CK-MB, and 
troponin, serially in all HT recipients. Sixth, we could not obtain 
and analyze the ECG of every donor heart in this study. Finally, 
clinical outcomes, such as sudden cardiac death or occurrence 
of heart failure, related primarily to conduction disturbance or 
acute graft rejection were not analyzed. Further larger long-
term follow-up study is warranted to confirm our hypothesis-
generating findings. In conclusion, close monitoring for newly 
developed RBBB and a relatively longer PR interval at 1 year 
following HT may help to identify patients at high risk for graft 
rejection. 
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